News & Events2021-05-16T11:37:20-06:00

Latest News

Health Canada Approves ORLADEYO

June 6th, 2022|

We are thrilled to share BioCryst Pharmaceutical's big announcement: Health Canada has approved their oral, once-daily ORLADEYO® (berotralstat) for the routine prevention of HAE attacks in patients 12

HAEi Advocacy Academy

January 6th, 2022|

HAE International is offering free, online advocacy courses. This extremely comprehensive program is designed to support people with HAE in everyday life. The courses are delivered in small manageable chunks and can

TAKHZYRO: One Step Closer

November 20th, 2020|

Amazing news! Canadian HAE patients are one step closer to gaining equitable access to the new treatment, TAKHZYRO! After months of negotiations, Takeda Canada announced it has completed

Go to Top